Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech PlatformNEW YORK and SALT LAKE CITY, March 31, 2026 (GLOBE NEWSWIRE) -- Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion (
NASDAQ: RXRX), a leading tech-bio company decoding biology through advanced data science and automation.
Citeline-Risklick Partnership Creates Smarter Protocols, from Design to OptimizationCiteline’s Best-in-Class Data and AI Combine with Risklick’s End-to-End Digital Protocol Workflow
Citeline Unveils Trialtrove+ and Sitetrove+Redefining Clinical Trial Planning with Next-Generation Solutions
In a First for Pharma, Citeline SmartSolutions Take AI to New Levels, Optimizing Clinical Trial Planning and Site SelectionProtocol SmartDesign and Investigator SmartSelect bring treatments to patients faster by accelerating clinical trial development
Citeline Introduces Global Patient InsightsProprietary Algorithm Optimizes Site Selection Process to Help Clinical Trial Sponsors Reach Diversity Enrollment Targets
Introducing Citeline’s TrialScope Disclose: Core DataClinical Trial Disclosure Solution Harmonizes Data Across Multiple Regions, Registries
Citeline to Share Exclusive Insights from 42nd Annual J.P. Morgan Healthcare ConferenceNEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Citeline, a Norstella company providing robust data and expert business intelligence to the pharmaceutical industry, will offer exclusive access to insights from the 42nd Annual J.P. Morgan Healthcare Conference (JPM) Jan. 8–11, 2024 in San Francisco.
Citeline Appoints Clinrol as Strategic Clinical Trial Partner Across APAC RegionNEW YORK, July 13, 2023 (GLOBE NEWSWIRE) -- Citeline, a global leader in clinical trial intelligence, has announced a strategic partnership with Clinrol, a clinical trial recruitment company, to expand and enhance patient recruitment for upcoming clinical trials across the Asia-Pacific (APAC) region. Clinrol is currently recruiting research participants in Australia for clinical trials in diabetes, cancer, dermatitis and other therapeutic areas.
Citeline Launches TrialScope Intelligence, Meeting the Growing Complexities of Clinical Trial DisclosureNEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- Clinical trial disclosure compliance is challenging, whether a sponsor is registering five trials or 500 trials. Compounding the complexity is the fact that no global standards exist for disclosure. With ever-changing global regulations, new requirements on the rise and the threat of monetary penalties, study sponsors are feeling the pressure to maintain compliance, minimize risk and safeguard their brand reputation.
Primal Pictures and the Anatomical Society Partner for Medical School 3D Digital Anatomy Learning ToolkitThe collaboration features explanatory videos, interactive models, clinical content & self-assessment exercises
Citeline to Unveil Capabilities of New Clinical Trial Workflow Solution at SCOPE 2023 in OrlandoNext-generation SaaS technology will enable study sponsors and CROs to better design, plan, and monitor clinical trials, from feasibility to start-up through enrollment
Citeline and EMIS Partner to Expand Clinical Trial Access in the UKNew alliance will boost access to clinical trials for thousands of individuals in the UK through their clinicians
